Radiofrequency Ablation Devices Market Global Industry Analysis and Forecast, 2015-2019

Radiofrequency is the electromagnetic wave frequency that lies in the range of 3 KHz to 300 GHz and refers to electrical oscillations. RF current penetrates only superficially into the skin unlike other forms of current and this particular aspect is responsible for greater control in thermal ablation of tissue. RF energy has been used in medicine for more than half a century and is currently used in a variety of applications. This report covers all major applications of radiofrequency ablation in healthcare such as cancer/ oncology or tumor management, cardiac rhythm management, pain management, hypertension, cosmetology or dermatology, gynecology and other emerging applications. Cardiac Rhythm Management is one of the most crucial areas in RF ablation devices and is considered a tried and tested treatment option. Atrial fibrillation is one of the most common forms of arrhythmia that occurs in over 35 million people across the world. RF ablation devices are also a boon to people suffering from tumors and cancer which is non-operable. Due to the minimally invasive nature of the procedures, most patients can be out of the hospital within a day and out of the operating room within a few hours of the procedure.

There are a large variety of devices that use RF electrical energy to generate heat. RF ablation catheters are long thin insulated and sheathed wires that have an exposed metal element at one end which delivers the therapeutic dose into the skin. These thin catheters are used for ablating nerves and tissue to reduce pain, arrhythmia and kill cancerous tumors. Some RF devices or probes are thicker and inserted directly into the target area through techniques such as arthroscopy for procedures such as chondroplasty with the help of controlled coagulation and ablation. Glow plasma discharge an effect created by RF energy on an electrode is also used for cutting and dissection of tissue during open invasive surgeries.

This report focuses on the radiofrequency ablation devices market in six geographies of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. The maturity and awareness of the technology in developed countries has ensured the leading position in terms of usage and demand. North America continues to have the greatest acceptance of RF devices and leads the global market followed by Europe. Demand from cosmetic industry has propelled body contouring RF devices in recent years throughout the world. In the past few years, the dynamics have changed quite rapidly for the overall acceptance and penetration of modern healthcare technology in underdeveloped regions as well with emerging economies pumping solid amount of investment in modernizing healthcare infrastructure. SA-BRC expects that new applications such as renal denervation, varicose vein treatment and others will grow significantly creating extremely lucrative market opportunity.

Free Sample Report@ http://www.sa-brc.com/Global-Radiofrequency-Ablation-Devices-Market-Assessment--Forecast-2015-2019/sample18

RF technology being the oldest is now facing challenges from emerging ablation technologies that use alternate energy sources such as cryoablation, ultrasound and microwave. The usage of all different types are currently restricted by limitations of technology however in coming years microwave ablation devices in particular are expected to grow in significance. Major players in this market are Medtronic Inc, Johnson & Johnson, Boston Scientific, St. Jude Medical, Stryker, Arthrex, Haylard Health, Angiodynamics, AtriCure, Sutter and Smith & Nephew. Overall the market is quite fragmented and the industry continues to see consolidation in major therapeutic areas such as cardiac ablation and general surgery.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.